Skip to main content

RED TEMATICA DE MICROBIOTA HUMANA APLICADA A LA SALUD

RED2022-134934-T

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Redes Investigación /Redes Excelencia
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free die

  • Marcos-Zambrano, Laura Judith
  • Lacruz-Pleguezuelos, Blanca
  • Aguilar-Aguilar, Elena
  • Marcos-Pasero, Helena
  • Valdés, Alberto
  • Loria-Kohen, Viviana
  • Cifuentes, Alejandro
  • Ramírez de Molina, Ana
  • Diaz-Ruiz, Alberto
  • Pancaldi, Vera
  • Carrillo de Santa Pau, Enrique
Non-responsive celiac disease (NRCD) challenges clinicians due to persistent symptoms despite a gluten-free diet (GFD). We present a cross-sectional pilot study including 39 NRCD patients to describe the underlying mechanisms contributing to symptom persistence by integrating different levels of data (fecal shotgun metagenomics, mucosal integrity markers, and metabolomic profiles) and using microbial networks to unravel the community structure of the patient's microbiome. Two distinct clusters of patients were identified based on clinical and demographic variables not influenced by gluten consumption. Cluster 1, labeled "Low-grade symptoms," displayed milder symptoms and lower inflammatory markers and a fragmented microbial network characterized by high modularity and a reliance on localized hubs, suggesting a microbial community under stress but capable of maintaining limited functionality. Cluster 2, named "High-grade symptoms," exhibited more severe symptoms, elevated inflammatory markers, and a more connected but antagonistic microbial network with a greater number of keystone taxa, including taxa associated with Th17 activation and inflammation. In contrast, the control network, representing asymptomatic treated celiac disease (tCD) patients, was highly interconnected, resilient, and cooperative, with a robust structure maintained even under simulated disruptions. Metabolomic analysis revealed differential metabolites between clusters, particularly those involved in amino acid metabolism pathways and microbial-derived metabolites such as indolelactic acid and mannitol, which were associated with symptom severity. This study identifies NRCD subgroups based on the gut microbiome and metabolic signatures associated with clinical manifestations, highlighting variations in microbial network stability and metabolite profiles as contributors to symptom persistence and potential therapeutic targets., [Importance]: Celiac disease (CD) is a chronic immune-mediated systemic disorder caused by consuming gluten in genetically susceptible individuals. There is currently no cure for CD, and the most effective treatment is maintaining a strict, lifelong gluten-free diet (GFD). This nutritional therapy aims to prevent the immune reaction triggered by gluten and promote the healing of the intestinal lining, resolving the clinical, serological, and histological abnormalities within 6-12 months. However, up to 30% of patients may continue to experience symptoms or exhibit laboratory abnormalities or intestinal inflammation suggestive of active CD, despite following a GFD. This challenge, which encompasses various diagnoses, is known as nonresponsive celiac disease (NRCD). In this study, we explored the role of intestinal microbiota in causing NRCD, finding an association between the persistence of symptoms and changes in mucosal integrity biomarkers, with different gut microbiome structures among NRCD patients, indicating a significant role of the microbiome in NRCD., This study has been funded by CD3DTech-CM (TEC-2024/BIO-167), a Research Grant 2020 of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID) to L.J.M.-Z; Project PID2023-150146OA-I00 founded by MICIU/AEI /10.13039/501100011033 and FEDER, UE; Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (‘A way to make Europe’); AI4FOOD-CM (Y2020/TCS-6654), RED2022-134934-T funded by MICIU/AEI/10.13039/501100011033. B.L.P is funded by Formación del ProfesoradoUniversitario grant (FPU22/04053) from the Spanish State Ministerio de Universidades., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Human gut microbiome study through metagenomics: Recent advances and challenges for clinical implementation, Estudio del microbioma intestinal humano mediante metagenómica: avances recientes y desafíos para su implementación clínica

  • Jiménez Arroyo, Cristina
  • Molinero, Natalia
  • Campo, Rosa del
  • Delgado, Susana
  • Moreno-Arribas, M. Victoria
[EN] Metagenomics has decisively advanced the study of the gut microbiome, enabling a better understanding of its importance for human health. Metataxonomics, based on the sequencing of the 16S rRNA gene, provides taxonomic profiles of prokaryotes, while shotgun metagenomics allows a comprehensive characterization of all DNA present in a sample. With adequate sequencing depth, the latter increases taxonomic resolution to the strain level and provides detailed information on the functional potential of the microbiota. However, the lack of standardization in sample collection and processing, sequencing technologies, and data management limits the comparability of results and their implementation in clinical laboratories. This review offers a practical and updated framework on metagenomic methodologies, data analysis, and the application of artificial intelligence tools, highlighting advances and best practices to facilitate the integration of functional microbiome analysis into clinical practice and to overcome current challenges., [ES] La metagenómica ha impulsado de manera decisiva el estudio del microbioma intestinal, lo que ha permitido comprender su importancia para la salud humana. La metataxonómica, basada en la secuenciación del gen del ARNr 16S, ofrece perfiles taxonómicos de procariotas, mientras que la metagenómica shotgun permite una caracterización más completa de todo el ADN presente en la muestra. Con una profundidad de secuenciación adecuada, esta última amplía la resolución taxonómica hasta el nivel de cepa y proporciona información detallada sobre el potencial funcional de la microbiota. Sin embargo, la falta de estandarización en la recolección y procesamiento de muestras, las tecnologías de secuenciación, y la interpretación y gestión de los datos, limita la comparación de resultados y su implementación en laboratorios clínicos. Esta revisión ofrece un marco práctico y actualizado sobre las metodologías metagenómicas, el análisis de datos y el uso de inteligencia artificial, destacando avances y buenas prácticas para facilitar su integración en la práctica médica y superar los desafíos actuales., The authors are grateful for the funding received from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIN) [Ministry of Science, Innovation and Universities] (Project PID2023-148419OB-I00, MICIN). We are grateful for the support of the Red Científica Conexión [Scientific Network Connection]-MICROBIOMA, funded by the Consejo Superior de Investigaciones Científicas (CSIC) [Spanish National Research Council], as well as the MIDAS Network (RED2022-134934-T) funded by MICIN., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet

  • Loria Kohen, Viviana Constanza
  • Marcos-Zambrano, Laura Judith
  • Lacruz-Pleguezuelos, Blanca
  • Aguilar-Aguilar, Elena
  • Marcos-Pasero, Helena
  • Valdés, Alberto
  • Cifuentes, Alejandro
  • Ramírez de Molina, Ana
  • Díaz-Ruiz, Alberto
  • Pancaldi, Vera
  • Carrillo de Santa Pau, Enrique
Non-responsive celiac disease (NRCD) challenges clinicians due to persistent symptoms despite a gluten-free diet (GFD). We present a cross-sectional pilot study including 39 NRCD patients to describe the underlying mechanisms contributing to symptom persistence by integrating different levels of data (fecal shotgun metagenomics, mucosal integrity markers, and metabolomic profiles) and using microbial networks to unravel the community structure of the patient's microbiome. Two distinct clusters of patients were identified based on clinical and demographic variables not influenced by gluten consumption. Cluster 1, labeled "Low-grade symptoms," displayed milder symptoms and lower inflammatory markers and a fragmented microbial network characterized by high modularity and a reliance on localized hubs, suggesting a microbial community under stress but capable of maintaining limited functionality. Cluster 2, named "High-grade symptoms," exhibited more severe symptoms, elevated inflammatory markers, and a more connected but antagonistic microbial network with a greater number of keystone taxa, including taxa associated with Th17 activation and inflammation. In contrast, the control network, representing asymptomatic treated celiac disease (tCD) patients, was highly interconnected, resilient, and cooperative, with a robust structure maintained even under simulated disruptions. Metabolomic analysis revealed differential metabolites between clusters, particularly those involved in amino acid metabolism pathways and microbial-derived metabolites such as indolelactic acid and mannitol, which were associated with symptom severity. This study identifies NRCD subgroups based on the gut microbiome and metabolic signatures associated with clinical manifestations, highlighting variations in microbial network stability and metabolite profiles as contributors to symptom persistence and potential therapeutic targets. Importance: Celiac disease (CD) is a chronic immune-mediated systemic disorder caused by consuming gluten in genetically susceptible individuals. There is currently no cure for CD, and the most effective treatment is maintaining a strict, lifelong gluten-free diet (GFD). This nutritional therapy aims to prevent the immune reaction triggered by gluten and promote the healing of the intestinal lining, resolving the clinical, serological, and histological abnormalities within 6-12 months. However, up to 30% of patients may continue to experience symptoms or exhibit laboratory abnormalities or intestinal inflammation suggestive of active CD, despite following a GFD. This challenge, which encompasses various diagnoses, is known as nonresponsive celiac disease (NRCD). In this study, we explored the role of intestinal microbiota in causing NRCD, finding an association between the persistence of symptoms and changes in mucosal integrity biomarkers, with different gut microbiome structures among NRCD patients, indicating a significant role of the microbiome in NRCD.